Leerink Partnrs Predicts Stronger Earnings for CVS Health

CVS Health Co. (NYSE:CVS) – Leerink Partnrs raised their FY2027 earnings per share estimates for shares of CVS Health in a research note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will post earnings of $8.23 per share for the year, up from their previous forecast of $8.16. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.14 per share. Leerink Partnrs also issued estimates for CVS Health’s FY2028 earnings at $9.36 EPS.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%.

A number of other research firms have also weighed in on CVS. Evercore ISI boosted their target price on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Monday, January 27th. Wells Fargo & Company boosted their target price on CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a report on Thursday. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Finally, Truist Financial boosted their price target on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $70.28.

CVS Health Stock Down 1.0 %

CVS stock opened at $65.71 on Friday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $82.68 billion, a PE ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. CVS Health has a 1-year low of $43.56 and a 1-year high of $80.75. The business’s 50 day simple moving average is $51.11 and its 200 day simple moving average is $56.08.

Institutional Trading of CVS Health

Institutional investors and hedge funds have recently modified their holdings of the business. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health during the 3rd quarter worth $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares in the last quarter. Stonebridge Financial Group LLC acquired a new position in CVS Health in the 4th quarter worth about $28,000. Hopwood Financial Services Inc. acquired a new position in CVS Health in the 4th quarter worth about $29,000. Finally, Livelsberger Financial Advisory acquired a new position in CVS Health in the 3rd quarter worth about $31,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. CVS Health’s dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.